Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a ran...

Por Cahn, Anthony, Hodgson, Simon, Wilson, Robert, Robertson, Jonathan, Watson, Joanna, Beerahee, Misba, Hughes, Steve C, Young, Graeme, Graves, Rebecca, Hall, David, van Marle, Sjoerd, Solari, Roberto
Publicado em 2013

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia

Por Ratti, Emiliangelo, Carpenter, David J., Zamuner, Stefano, Fernandes, Sofia, Squassante, Lisa, Danker-Hopfe, Heidi, Archer, Graeme, Robertson, Jonathan, Alexander, Robert, Trist, David G., Merlo-Pich, Emilio
Publicado em 2013

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor

Por Lazaar, Aili L., Yang, Lucy, Boardley, Rebecca L., Goyal, Navin S., Robertson, Jonathan, Baldwin, Sandra J., Newby, David E., Wilkinson, Ian B., Tal‐Singer, Ruth, Mayer, Ruth J., Cheriyan, Joseph
Publicado no Br J Clin Pharmacol (2016)